Provided by Tiger Trade Technology Pte. Ltd.

Incyte

113.22
+0.49000.43%
Volume:779.28K
Turnover:88.95M
Market Cap:22.95B
PE:14.42
High:115.49
Open:112.82
Low:112.82
Close:112.73
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:0.39
T/O Rate:0.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.62
PE(LYR):17.66

Loading ...

Knight Therapeutics Wins Brazil Anvisa Approval for Niktimvo to Treat Chronic GVHD

Reuters
·
Oct 06

Knight Therapeutics Announces Regulatory Approval of Niktimvo® in Brazil

THOMSON REUTERS
·
Oct 06

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA), Xeris Pharmaceuticals (XERS) and Incyte (INCY)

TIPRANKS
·
Oct 06

Incyte Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Oct 06

Stifel Adjusts Price Target on Incyte to $157 From $145, Keeps Buy Rating

MT Newswires Live
·
Oct 05

Incyte Price Target Raised to $157.00/Share from $145.00 by Stifel

Dow Jones
·
Oct 05

Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 03

Celcuity Appoints Ex-Incyte CFO David Gryska to Board

Reuters
·
Oct 02

Incyte Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 02

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 02

Incyte Price Target Raised to $128.00/Share from $116.00 by Wells Fargo

Dow Jones
·
Oct 01

Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating

MT Newswires Live
·
Oct 01

Analysts Offer Insights on NA Companies: Micron (MU), Exxon Mobil (XOM) and Incyte (INCY)

TIPRANKS
·
Oct 01

Halozyme Appoints Jim Daly to Board of Directors

Reuters
·
Oct 01

Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 30

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
Sep 29

Incyte management to meet with Oppenheimer

TIPRANKS
·
Sep 29

MiniMed Names Sheila Denton General Counsel, Corporate Secretary

Reuters
·
Sep 28

Mirum Rises on FDA Nod for Rare Bone Disorder Drug

Reuters
·
Sep 28

Incyte Price Target Raised to $152.00/Share from $150.00 by HC Wainwright & Co.

Dow Jones
·
Sep 28